Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397) |
---|
05/17/2011 | CA2397194C Alpha v integrin receptor antagonists |
05/17/2011 | CA2197672C Tetrahydrofuran antifungals |
05/14/2011 | CA2739869A1 Radiolabelled inhibitors of the glycine 1 transporter |
05/12/2011 | WO2011057054A1 Aryl- and heteroarylcarbonyl derivatives of hexahydroindenopyridine and octahydrobenzoquinoline |
05/12/2011 | WO2011055770A1 Fused heterocyclic compound |
05/12/2011 | WO2011055215A2 Novel kinase modulators |
05/12/2011 | WO2011054848A1 Thetrahydroquinolines derivatives as bromodomain inhibitors |
05/12/2011 | WO2010147898A3 Small molecule inhibitors of spleen tyrosine kinase (syk) |
05/12/2011 | WO2010131054A9 Redox drug derivatives |
05/12/2011 | US20110112309 Preparation process useful in synthesis of atorvastatin |
05/12/2011 | US20110112293 Purification Strategy for Direct Nucleophilic Procedures |
05/12/2011 | US20110112154 Compounds, compositions and methods |
05/12/2011 | US20110112146 Chromene modulators of chemokine receptor activity |
05/12/2011 | US20110112145 Salts Of Methyl 2-((R))-(3-Chlorophenyl)((R)-1-((S)-2-(Methylamino)-3((R)-tetrahydro-2H-Pyran-3-YL)Propylcarbamoyl)Piperidin-3-YL)Methoxy)Ethylcarbamate |
05/12/2011 | US20110112142 Novel estrogen receptor ligands |
05/12/2011 | US20110112140 Inhibitor of plasminogen activator inhibitor-1 |
05/12/2011 | US20110112118 2,4-Diaminoquinazolines for Spinal Muscular Atrophy |
05/12/2011 | US20110112110 Antiproliferative compounds and therapeutic uses thereof |
05/12/2011 | US20110112103 5-hydroxypyrimidine-4-carboxamide compound |
05/12/2011 | US20110112096 Pyrimidine derivatives as kinase inhibitors |
05/12/2011 | US20110112092 Aminoquinoline derivatives and their use as adenosine a3 ligands |
05/12/2011 | US20110112084 Bicyclic androgen and progesterone receptor modulator compounds and methods |
05/12/2011 | US20110112076 Selective hydroxamic acid based mmp-12 and mmp-13 inhibitors |
05/12/2011 | US20110112073 Compositions and methods relating to heat shock transcription factor activating compounds and targets thereof |
05/12/2011 | US20110112071 Novel heterocyclidene acetamide derivative |
05/12/2011 | US20110112066 Preventive/remedy for retinal nerve diseases containing alkyl ether derivatives or salts thereof |
05/12/2011 | US20110112065 Modulators of dopamine neurotransmission |
05/12/2011 | US20110112063 Pyrimidine derivatives as kinase inhibitors |
05/12/2011 | US20110112060 1,2,3-trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto |
05/12/2011 | US20110111162 Indolium compound and optical recording material containing the same |
05/12/2011 | US20110111046 N1-Pyrazolospiroketone Acetyl-CoA Carboxylase Inhibitors |
05/12/2011 | CA2780149A1 Ire-1.alpha. inhibitors |
05/12/2011 | CA2779989A1 Quinazoline compounds |
05/12/2011 | CA2779574A1 Novel kinase modulators |
05/12/2011 | CA2778161A1 Aryl- and heteroarylcarbonyl derivatives of hexahydroindenopyridine and octahydrobenzoquinoline |
05/11/2011 | EP2319890A1 Azo compound, azo pigment, pigment dispersion, color composition, inkjet recording ink, color composition for color filter, color filter, and method for preparing color composition for color filter |
05/11/2011 | EP2319856A1 Methods and compositions for treating hepatitis c virus |
05/11/2011 | EP2319843A1 Substituted pyrrole derivatives and their use as HMG-CO inhibitors |
05/11/2011 | EP2319837A1 Benzimidazole derivatives and their use for modulating the GABAa receptor complex |
05/11/2011 | EP2319831A1 Novel pyrrole derivative having, as substituents, ureide group, aminocarbonyl group and bicyclic group which may have substituent |
05/11/2011 | EP2319527A2 BAFF, inhibitors thereof and their use in the modulation of the B-cell response |
05/11/2011 | EP2318396A1 A crystalline form of posaconazole |
05/11/2011 | EP2318378A2 Quinazoline derivatives |
05/11/2011 | EP2318376A1 Bi-1h-benzimidazoles as hepatitis c virus inhibitors |
05/11/2011 | EP2318374A2 Insecticidal benzenedicarboxamide derivative |
05/11/2011 | EP2134708B1 3-cyano-4-(4-tetrahydropyran-phenyl)-pyridin-2-one derivatives |
05/11/2011 | EP2134699B1 2-aryl-5-heterocyclyl-cyclohexane-1,3-dione compounds and their use as herbicides |
05/11/2011 | EP2042171B1 Therapeutic or prophylactic agent for allergic dermatitis |
05/11/2011 | EP1789036B1 5-[3-(4-benzyloxyphenylthio)-fur-2-yl]-imidazolidin-2, 4-dione and analogues as inhibitors of macrophage elastase |
05/11/2011 | CN102056920A Tetrazole compounds as orexin receptor antagonists |
05/11/2011 | CN102056905A Novel uracil compound having inhibitory activity on human deoxyuridine triphosphatase or salt thereof |
05/11/2011 | CN102056904A Indane derivatives as AMPA receptor modulators |
05/11/2011 | CN102056903A New drug for inhibiting aggregation of proteins involved in diseases linked to protein aggregation and/or neurodegenerative diseases |
05/11/2011 | CN102056894A Homocysteine synthase inhibitor |
05/11/2011 | CN102050817A Synthetic method of N-(4-oxo-6-X-1H-benzofuran-2-tetrazole)-4-phenylbutoxy benzamide |
05/11/2011 | CN102050807A 3-aryl-4-(2-acyloxy ethyoxyl)-2(5H)-furanone compound and preparation method and application thereof |
05/11/2011 | CN102050793A 4(3H) quinazolinone derivatives with antitumor activity |
05/11/2011 | CN102050777A Method for preparing N-substituted-L-methyl tryptophan ester |
05/11/2011 | CN102050758A Novel amide derivatives and medicinal use thereof |
05/11/2011 | CN101072561B Diaminoalkane aspartic protease inhibitors |
05/10/2011 | USRE42353 Quinazoline derivatives and pharmaceutical compositions containing them |
05/10/2011 | US7939685 Hydroxylation of β-dicarbonyls with zirconium catalysts |
05/10/2011 | US7939670 Nociceptin analogs |
05/10/2011 | US7939657 N-substituted benzene sulfonamides |
05/10/2011 | US7939549 1,2-dihydropyridine compounds, manufacturing method thereof and use thereof |
05/10/2011 | CA2614746C Heteroaryl benzamide derivatives for use as glk activators in the treatment of diabetes |
05/10/2011 | CA2467471C Derivatives of andrimid and moiramide b having antibacterial properties |
05/10/2011 | CA2463102C Pyrazolidinone compounds as ligands of the prostaglandin ep2 and/or ep4 receptors |
05/10/2011 | CA2433158C Pyridone derivatives having a binding activity to the cannabinoid type 2 receptor |
05/05/2011 | WO2011053706A1 4-substituted-2-phenoxy-phenylamine delta opioid receptor modulators |
05/05/2011 | WO2011051961A1 Compounds for the treatment of dyslipidemia and related diseases |
05/05/2011 | WO2011051853A1 Manufacturing process for preparing enaniomerically pure 8- aryloctanoic acid derivatives such as aliskiren |
05/05/2011 | WO2011051540A1 Androgen receptor modulating compounds |
05/05/2011 | WO2011051478A1 Novel oxime derivatives and their use as allosteric modulators of metabotropic glutamate receptors |
05/05/2011 | WO2011051242A1 Co-crystal of 4-{[(6-chloropyrid-3-yl)methyl](2,2-difluoroethyl)amino}furan-2(5h)-one with salicylic acid and use thereof as pesticide |
05/05/2011 | WO2011051241A1 Co-crystal of 4-{[(6-chloropyrid-3-yl)methyl](2,2-difluoroethyl)amino}furan-2(5h)-one with oxalic acid and use thereof as pesticide |
05/05/2011 | WO2011051240A1 Co-crystal of 4-{[(6-chloropyrid-3-yl)methyl](2,2-difluoroethyl)amino}furan-2(5h)-one with benzoic acid and use thereof as a pesticide |
05/05/2011 | WO2011051201A1 Positive allosteric modulators (pam) |
05/05/2011 | WO2011051151A1 Novel solid form of 4-[[(6-chloropyridin-3-yl)methyl](2,2-difluoroethyl)amino]furan-2(5h)-one |
05/05/2011 | WO2011025938A3 Raf inhibitor compounds and methods of use thereof |
05/05/2011 | WO2011006803A9 3-0x0-2, 3, -dihydro-1h-isoindole-4-carboxamides with selective parp-1 inhibition |
05/05/2011 | WO2011006794A9 3-oxo-2, 3-dihydro-1h-isoindole-4-carboxamides as parp inhibitors |
05/05/2011 | WO2010147430A3 Novel c-aryl glucoside sglt2 inhibitors and pharmaceutical composition comprising same |
05/05/2011 | WO2010109185A3 Process for the preparation of doxazosin and salts thereof |
05/05/2011 | US20110105767 Manufacturing process for enantiomerically pure 8-Aryloctanoic acids as Aliskiren |
05/05/2011 | US20110105749 Triazole compounds that modulate hsp90 activity |
05/05/2011 | US20110105747 Quinoline derivative and quinazoline derivative inhibiting self-phosphorylation of hepatocytus proliferator receptor, and medicinal composition containing the same |
05/05/2011 | US20110105573 Benzimidazole acetic acids exhibiting crth2 receptor antagonism and uses thereof |
05/05/2011 | US20110105567 Pyrrole Compounds Having Sphingosine-1-Phosphate Receptor Agonist Or Antagonist Biological Activity |
05/05/2011 | US20110105543 Novel triaryl derivatives useful as modulators of nicotinic acetylcholine receptors |
05/05/2011 | US20110105533 Heterocyclic Sulfonamides, Uses and Pharmaceutical Compositions Thereof |
05/05/2011 | US20110105528 1-(7-(hexahydropyrrolo [3, 4-c] pyrrol-2 (1h)-yl) quinolin-4-yl) -3- (pyrazin-2-yl) urea derivatives and related compounds as glycogen synthase kinase 3 (gsk-3) |
05/05/2011 | US20110105525 Pharmaceutical compositions containing a crystalline form of posaconazole |
05/05/2011 | US20110105522 Ketoconazole-derivative antagonist of human pregnane x receptor and uses thereof |
05/05/2011 | US20110105513 AMINO-QUINOXALINE AND AMINO-QUINOLINE COMPOUNDS FOR USE AS ADENOSINE A2a RECEPTOR ANTAGONISTS |
05/05/2011 | US20110105506 Diaminoalkane aspartic protease inhibitors |
05/05/2011 | US20110105503 Aralkyl piperidine derivatives and their uses as antalgic or ataractic agent |
05/05/2011 | US20110105485 Alpha-(N-Sulfonamido)Acetamide Derivatives as Beta-Amyloid Inhibitors |
05/05/2011 | US20110105475 Benzofurane, benzothiophene, benzothiazol derivatives as fxr modulators |
05/05/2011 | US20110105472 Diaminopyrimidines as crop protection agents |